Pharmaceuticals
Green Discovery Chemistry Award
Purpose: To recognize outstanding efforts in discovery chemistry that demonstrate compelling environmental, safety and/or efficiency improvements through green chemistry and engineering.
Nominations are due December 1, 2024 at 11:59 EST (GMT-5).
Proposed PFAS Restriction Signals Supply Chain Shift, Need for Innovation in Pharmaceutical Industry
Computational chemistry and Digitalization Platform
DUDE CHEM is a German-based startup dedicated to advancing sustainable chemical production. The company aims to revolutionize the chemical-pharmaceutical industry by developing greener active pharmaceutical ingredients (API) and intermediates.
Supercritical Fluids Conference (SFC) USA 2024
The Green Chemistry Group is pleased to announce the return of the SFC USA 2024 conference at the BMS Princeton Pike site in Lawrence Township, NJ on October 23rd-25th, 2024. The conference will begin with a short course taught by experts in the field, followed by two days of oral and poster scientific presentations. Leading vendors of SFC instrumentation and supplies will exhibit their wares, and present numerous vendor workshops.
Industrial research: Drug companies must adopt green chemistry
In the past decade, many large pharmaceutical companies have moved to using green-chemistry practices for drug discovery, development and manufacturing. These firms include ours, Amgen, and others such as the Merck Group, Abbott, Johnson & Johnson and Roche. Ranking systems such as the Dow Jones Sustainability Indices and the Pacific Sustainability Index1 track how well firms are doing.
Key Green Chemistry research areas from a pharmaceutical manufacturers’ perspective revisited
The ACS Green Chemistry Institute® Pharmaceutical Roundtable (GCIPR) was developed in 2005 to encourage the integration of green chemistry and green engineering into the pharmaceutical industry. One of the strategic priorities of the Roundtable is to inform and influence the research agenda and an early step was the publication of a paper on key green chemistry research areas (KRA) from a pharmaceutical manufacturers’ perspective. The publication was followed up with the ongoing GCIPR Research Grant Programme.
Embedding sustainable practices into pharmaceutical R&D: what are the challenges?
The world's population is predicted to exceed 9 billion by 2050, with growth in the developing world projected to triple global resource consumption. Industries, including pharmaceuticals, will still be competing for one Earth's worth of resources to meet this tripled demand. In order to thrive in the future, it is clear that routes to pharmaceuticals, which currently produce in the order of 100 kg of waste for each kilogram of drug in an optimized process, will need to be more efficient and sustainable.
Pagination
- Page 1
- Next page